Hence, the gene expression inference from our nucleosome positioning mapping approach suggested that our observations from the cell culture systems are applicable to these clinical cases and, furthermore, that FLT3 is indeed not the cancer driver gene within this amplicon in CRC. The gene discussed is FLT3; the disease is colorectal carcinoma.